Paratek Pharmaceuticals, Inc. reiterated guidance for the year 2022. Based on current performance, the company reiterating the company's full year 2022 guidance.
1st Jan change | Capi. | |
---|---|---|
+32.07% | 694B | |
+29.39% | 593B | |
-1.48% | 371B | |
+20.02% | 331B | |
+7.22% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.51% | 169B |